tradingkey.logo

Exact Sciences Corp

EXAS
67.030USD
-0.720-1.06%
收盤 11/14, 16:00美東報價延遲15分鐘
12.70B總市值
虧損本益比TTM

Exact Sciences Corp

67.030
-0.720-1.06%

關於 Exact Sciences Corp 公司

Exact Sciences Corporation 是一家全球先進的癌症診斷公司。該公司提供一系列用於早期癌症檢測和治療指導的產品。其產品和服務專注於篩查和精準腫瘤學測試。該公司的研發工作主要集中在三個主要領域:結直腸癌篩查、MCED 測試開發和 MRD 測試開發。該公司的產品和服務包括 Cologuard 測試、Oncotype DX 乳腺復發評分測試、Oncotype DX 乳腺 DCIS 評分測試、Oncotype DX 結腸復發評分測試和 OncoExTra 測試。該公司的旗艦篩查產品 Cologuard 測試是一種非侵入性、基於糞便的脫氧核糖核酸 (sDNA) 篩查測試,它利用多目標方法檢測與結直腸癌和癌前病變相關的 DNA 和血紅蛋白生物標誌物。Oncotype DX 乳腺復發評分測試檢查患者乳腺腫瘤組織中 21 個基因的活性。

Exact Sciences Corp簡介

公司代碼EXAS
公司名稱Exact Sciences Corp
上市日期Jan 30, 2001
CEOMr. Kevin T. Conroy
員工數量6900
證券類型Ordinary Share
年結日Jan 30
公司地址5505 Endeavor Lane
城市MADISON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編53719
電話16082845700
網址https://www.exactsciences.com/
公司代碼EXAS
上市日期Jan 30, 2001
CEOMr. Kevin T. Conroy

Exact Sciences Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.14M
-20.54%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
60.76K
-16.49%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+18.67%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
28.90K
+22.97%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
23.04K
-11.04%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Independent Director
Independent Director
17.17K
+80.75%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
16.38K
+156.47%
Mr. Aaron Bloomer
Mr. Aaron Bloomer
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
13.84K
--
Mr. Michael J. (Mike) Barber, M.D.
Mr. Michael J. (Mike) Barber, M.D.
Independent Director
Independent Director
13.14K
+121.18%
Mr. James E. Doyle
Mr. James E. Doyle
Lead Independent Director
Lead Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin T. Conroy
Mr. Kevin T. Conroy
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.14M
-20.54%
Ms. Katherine S. (Kay) Zanotti
Ms. Katherine S. (Kay) Zanotti
Independent Director
Independent Director
60.76K
-16.49%
Mr. Daniel J. (Dan) Levangie
Mr. Daniel J. (Dan) Levangie
Independent Director
Independent Director
34.31K
+18.67%
Ms. Shacey Petrovic
Ms. Shacey Petrovic
Independent Director
Independent Director
28.90K
+22.97%
Mr. Brian Baranick
Mr. Brian Baranick
Executive Vice President, General Manager - Precision Oncology
Executive Vice President, General Manager - Precision Oncology
23.04K
-11.04%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Independent Director
Independent Director
17.17K
+80.75%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Commercial
387.50M
47.78%
Medicare Parts B & C
274.49M
33.84%
Other
93.84M
11.57%
International
55.26M
6.81%
地區USD
名稱
營收
佔比
United States (Country)
755.83M
93.19%
Outside of united states
55.26M
6.81%
業務
地區
業務USD
名稱
營收
佔比
Commercial
387.50M
47.78%
Medicare Parts B & C
274.49M
33.84%
Other
93.84M
11.57%
International
55.26M
6.81%

股東統計

更新時間: 23 小時前
更新時間: 23 小時前
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.38%
Capital World Investors
8.52%
Fidelity Management & Research Company LLC
8.12%
BlackRock Institutional Trust Company, N.A.
3.78%
Wellington Management Company, LLP
2.81%
其他
67.40%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.38%
Capital World Investors
8.52%
Fidelity Management & Research Company LLC
8.12%
BlackRock Institutional Trust Company, N.A.
3.78%
Wellington Management Company, LLP
2.81%
其他
67.40%
股東類型
持股股東
佔比
Investment Advisor
52.84%
Investment Advisor/Hedge Fund
26.25%
Hedge Fund
6.43%
Pension Fund
2.25%
Research Firm
2.03%
Individual Investor
0.91%
Bank and Trust
0.56%
Sovereign Wealth Fund
0.48%
Private Equity
0.32%
其他
7.92%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1362
183.28M
96.81%
-19.18M
2025Q2
1403
202.48M
106.98%
+2.53M
2025Q1
1424
199.78M
106.03%
-445.52K
2024Q4
1411
200.72M
108.09%
-225.66K
2024Q3
1375
190.82M
103.28%
-5.17M
2024Q2
1358
185.25M
100.40%
+6.59M
2024Q1
1347
168.41M
92.78%
-6.10M
2023Q4
1356
165.31M
91.41%
-11.01M
2023Q3
1337
167.70M
92.83%
-6.22M
2023Q2
1354
166.38M
92.24%
-10.65M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
17.87M
9.44%
+303.00K
+1.73%
Jun 30, 2025
Capital World Investors
18.20M
9.61%
+364.75K
+2.05%
Jun 30, 2025
Fidelity Management & Research Company LLC
23.28M
12.3%
-852.45K
-3.53%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
7.04M
3.72%
-640.89K
-8.35%
Jun 30, 2025
Wellington Management Company, LLP
12.00M
6.34%
-497.53K
-3.98%
Jun 30, 2025
State Street Investment Management (US)
5.38M
2.84%
-1.23M
-18.67%
Jun 30, 2025
MFS Investment Management
2.96M
1.57%
+1.46M
+97.24%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.24M
1.71%
-29.40K
-0.90%
Jun 30, 2025
查看更多

持股ETF

更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
First Trust Nasdaq Lux Digi Health Solutions ETF
3.78%
First Trust NYSE Arca Biotechnology Index Fund
3.27%
Invesco Biotechnology & Genome ETF
3.17%
Alger Mid Cap 40 ETF
2.49%
First Trust Indxx Medical Devices ETF
2.34%
SPDR S&P Biotech ETF
2.06%
iShares Health Innovation Active ETF
1.84%
Franklin Genomic Advancements ETF
1.81%
ROBO Global Healthcare Technology & Innovation ETF
1.74%
VanEck Biotech ETF
1.44%
查看更多
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比3.78%
First Trust NYSE Arca Biotechnology Index Fund
佔比3.27%
Invesco Biotechnology & Genome ETF
佔比3.17%
Alger Mid Cap 40 ETF
佔比2.49%
First Trust Indxx Medical Devices ETF
佔比2.34%
SPDR S&P Biotech ETF
佔比2.06%
iShares Health Innovation Active ETF
佔比1.84%
Franklin Genomic Advancements ETF
佔比1.81%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.74%
VanEck Biotech ETF
佔比1.44%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI